Zimmer A - Search Results

1

Antisense delivery using protamine-oligonucleotide particles.

Junghans M, Kreuter J, Zimmer A. Junghans M, et al. Among authors: zimmer a. Nucleic Acids Res. 2000 May 15;28(10):E45. doi: 10.1093/nar/28.10.e45. Nucleic Acids Res. 2000. PMID: 10773093 Free PMC article.

2

Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation.

Dinauer N, Lochmann D, Demirhan I, Bouazzaoui A, Zimmer A, Chandra A, Kreuter J, von Briesen H. Dinauer N, et al. Among authors: zimmer a. J Control Release. 2004 May 18;96(3):497-507. doi: 10.1016/j.jconrel.2004.02.020. J Control Release. 2004. PMID: 15120905

3

Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution.

Vogel V, Lochmann D, Weyermann J, Mayer G, Tziatzios C, van den Broek JA, Haase W, Wouters D, Schubert US, Kreuter J, Zimmer A, Schubert D. Vogel V, et al. Among authors: zimmer a. J Control Release. 2005 Mar 2;103(1):99-111. doi: 10.1016/j.jconrel.2004.11.029. Epub 2005 Jan 8. J Control Release. 2005. PMID: 15710504

4

Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides.

Junghans M, Loitsch SM, Steiniger SC, Kreuter J, Zimmer A. Junghans M, et al. Among authors: zimmer a. Eur J Pharm Biopharm. 2005 Jul;60(2):287-94. doi: 10.1016/j.ejpb.2005.01.006. Eur J Pharm Biopharm. 2005. PMID: 15939239

5

Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides.

Zobel HP, Kreuter J, Werner D, Noe CR, Kümel G, Zimmer A. Zobel HP, et al. Among authors: zimmer a. Antisense Nucleic Acid Drug Dev. 1997 Oct;7(5):483-93. doi: 10.1089/oli.1.1997.7.483. Antisense Nucleic Acid Drug Dev. 1997. PMID: 9361907

6

Enhanced antisense efficacy of oligonucleotides adsorbed to monomethylaminoethylmethacrylate methylmethacrylate copolymer nanoparticles.

Zobel HP, Junghans M, Maienschein V, Werner D, Gilbert M, Zimmermann H, Noe C, Kreuter J, Zimmer A. Zobel HP, et al. Among authors: zimmer a. Eur J Pharm Biopharm. 2000 May;49(3):203-10. doi: 10.1016/s0939-6411(00)00080-1. Eur J Pharm Biopharm. 2000. PMID: 10799810

7

Phosphodiester and phosphorothioate oligonucleotide condensation and preparation of antisense nanoparticles.

Junghans M, Kreuter J, Zimmer A. Junghans M, et al. Among authors: zimmer a. Biochim Biophys Acta. 2001 Jan 12;1544(1-2):177-88. doi: 10.1016/s0167-4838(00)00219-3. Biochim Biophys Acta. 2001. PMID: 11341927

8

Physicochemical characterization of protamine-phosphorothioate nanoparticles.

Lochmann D, Vogel V, Weyermann J, Dinauer N, von Briesen H, Kreuter J, Schubert D, Zimmer A. Lochmann D, et al. Among authors: zimmer a. J Microencapsul. 2004 Sep;21(6):625-41. doi: 10.1080/02652040400000504. J Microencapsul. 2004. PMID: 15762320

9

Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part II: characterization of antisense oligonucleotides loaded copolymer nanoparticles.

Zobel HP, Stieneker F, Atmaca-Abdel Aziz S, Gilbert M, Werner D, Noe CR, Kreuter J, Zimmer A. Zobel HP, et al. Among authors: zimmer a. Eur J Pharm Biopharm. 1999 Jul;48(1):1-12. doi: 10.1016/s0939-6411(99)00003-x. Eur J Pharm Biopharm. 1999. PMID: 10477322

10

Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction.

Mayer G, Vogel V, Weyermann J, Lochmann D, van den Broek JA, Tziatzios C, Haase W, Wouters D, Schubert US, Zimmer A, Kreuter J, Schubert D. Mayer G, et al. Among authors: zimmer a. J Control Release. 2005 Aug 18;106(1-2):181-7. doi: 10.1016/j.jconrel.2005.04.019. J Control Release. 2005. PMID: 16002173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

986 results

Search Page

Filters